$1.26 Billion is the total value of Ikarian Capital, LLC's 164 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 84.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | Sell | SPDR S&P 500 ETF TRput | $215,852,000 | -11.8% | 700,000 | -26.3% | 17.18% | -6.7% |
| BPMC | Buy | BLUEPRINT MEDICINES CORPput | $31,200,000 | +708.3% | 400,000 | +506.1% | 2.48% | +756.2% |
| QQQ | New | INVESCO QQQ TRcall | $30,950,000 | – | 125,000 | +100.0% | 2.46% | – |
| CCXI | New | CHEMOCENTRYX INCput | $28,770,000 | – | 500,000 | +100.0% | 2.29% | – |
| ARGX | ARGENX SEput | $28,334,000 | +71.0% | 125,800 | 0.0% | 2.26% | +81.0% | |
| XBI | SPDR SER TRput | $27,988,000 | +44.6% | 250,000 | 0.0% | 2.23% | +53.0% | |
| RETA | New | REATA PHARMACEUTICALS INCcall | $26,071,000 | – | 167,100 | +100.0% | 2.08% | – |
| ZYME | New | ZYMEWORKS INCcall | $25,249,000 | – | 700,000 | +100.0% | 2.01% | – |
| FXI | New | ISHARES TRput | $23,820,000 | – | 600,000 | +100.0% | 1.90% | – |
| ASND | New | ASCENDIS PHARMA A Scall | $21,446,000 | – | 145,000 | +100.0% | 1.71% | – |
| CLDX | New | CELLDEX THERAPEUTICS INC NEW | $21,417,000 | – | 1,647,439 | +100.0% | 1.70% | – |
| VNQ | New | VANGUARD INDEX FDSput | $19,633,000 | – | 250,000 | +100.0% | 1.56% | – |
| MRNA | New | MODERNA INCput | $19,263,000 | – | 300,000 | +100.0% | 1.53% | – |
| ACC | New | AMERICAN CAMPUS CMNTYS INCput | $19,228,000 | – | 550,000 | +100.0% | 1.53% | – |
| XLRN | Sell | ACCELERON PHARMA INCcall | $17,882,000 | -5.3% | 187,700 | -10.7% | 1.42% | +0.1% |
| MYOK | Sell | MYOKARDIA INCput | $17,450,000 | -11.3% | 180,600 | -57.0% | 1.39% | -6.1% |
| OCUL | Buy | OCULAR THERAPEUTIX INC | $17,126,000 | +121.9% | 2,055,977 | +31.9% | 1.36% | +135.0% |
| MRTX | Buy | MIRATI THERAPEUTICS INCput | $17,126,000 | +49.6% | 150,000 | +0.7% | 1.36% | +58.3% |
| BPMC | New | BLUEPRINT MEDICINES CORP | $15,730,000 | – | 201,662 | +100.0% | 1.25% | – |
| INCY | New | INCYTE CORPcall | $15,596,000 | – | 150,000 | +100.0% | 1.24% | – |
| TARA | New | PROTARA THERAPEUTICS INC | $15,480,000 | – | 527,964 | +100.0% | 1.23% | – |
| OHI | New | OMEGA HEALTHCARE INVS INCput | $14,865,000 | – | 500,000 | +100.0% | 1.18% | – |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS INcall | $14,520,000 | +215.8% | 230,000 | +155.6% | 1.16% | +234.1% |
| BTAI | Sell | BIOXCEL THERAPEUTICS INC | $14,250,000 | -8.1% | 268,818 | -61.2% | 1.13% | -2.7% |
| XLF | New | SELECT SECTOR SPDR TRput | $13,884,000 | – | 600,000 | +100.0% | 1.10% | – |
| ZGNX | Sell | ZOGENIX INC | $13,709,000 | +0.9% | 507,559 | -7.6% | 1.09% | +6.8% |
| New | HORIZON THERAPEUTICS PUB LTDcall | $13,700,000 | – | 246,500 | +100.0% | 1.09% | – | |
| New | NOVAVAX INCput | $13,694,000 | – | 164,300 | +100.0% | 1.09% | – | |
| KALV | Buy | KALVISTA PHARMACEUTICALS INC | $13,472,000 | +86.0% | 1,113,395 | +17.6% | 1.07% | +96.7% |
| CRSP | CRISPR THERAPEUTICS AGput | $13,162,000 | +73.3% | 179,100 | 0.0% | 1.05% | +83.4% | |
| RETA | Sell | REATA PHARMACEUTICALS INCput | $13,059,000 | -27.6% | 83,700 | -33.0% | 1.04% | -23.4% |
| SBBP | Sell | STRONGBRIDGE BIOPHARMA PLC | $12,365,000 | +92.8% | 3,271,238 | -3.6% | 0.98% | +104.1% |
| ZGNX | Sell | ZOGENIX INCput | $11,865,000 | -36.0% | 439,300 | -41.4% | 0.94% | -32.3% |
| ITCI | New | INTRA CELLULAR THERAPIES INCcall | $11,790,000 | – | 459,300 | +100.0% | 0.94% | – |
| CRBP | New | CORBUS PHARMACEUTICALS HLDGSput | $11,327,000 | – | 1,350,000 | +100.0% | 0.90% | – |
| MPW | New | MEDICAL PPTYS TRUST INCput | $11,280,000 | – | 600,000 | +100.0% | 0.90% | – |
| SCPH | Buy | SCPHARMACEUTICALS INC | $10,809,000 | +36.0% | 1,468,647 | +36.8% | 0.86% | +44.1% |
| BPMC | Buy | BLUEPRINT MEDICINES CORPcall | $10,015,000 | +242.5% | 128,400 | +156.8% | 0.80% | +262.3% |
| ACAD | Sell | ACADIA PHARMACEUTICALS INCput | $9,694,000 | -4.4% | 200,000 | -16.7% | 0.77% | +1.0% |
| ARDX | Sell | ARDELYX INC | $9,637,000 | +15.9% | 1,392,565 | -4.8% | 0.77% | +22.7% |
| MDGL | New | MADRIGAL PHARMACEUTICALS INCcall | $9,592,000 | – | 84,700 | +100.0% | 0.76% | – |
| SAGE | Buy | SAGE THERAPEUTICS INCcall | $9,534,000 | +115.2% | 229,300 | +48.6% | 0.76% | +127.9% |
| CVM | Buy | CEL SCI CORPput | $9,514,000 | +64.9% | 637,700 | +27.5% | 0.76% | +74.4% |
| STSA | New | SATSUMA PHARMACEUTICALS INC | $9,457,000 | – | 328,824 | +100.0% | 0.75% | – |
| XLE | New | SELECT SECTOR SPDR TRput | $9,201,000 | – | 243,100 | +100.0% | 0.73% | – |
| GOSS | New | GOSSAMER BIO INC | $9,152,000 | – | 703,999 | +100.0% | 0.73% | – |
| CRBP | New | CORBUS PHARMACEUTICALS HLDGScall | $8,390,000 | – | 1,000,000 | +100.0% | 0.67% | – |
| SAGE | Buy | SAGE THERAPEUTICS INC | $8,364,000 | +59.1% | 201,151 | +9.9% | 0.67% | +68.6% |
| FGEN | FIBROGEN INCcall | $8,106,000 | +16.6% | 200,000 | 0.0% | 0.64% | +23.3% | |
| BTAI | Buy | BIOXCEL THERAPEUTICS INCcall | $7,888,000 | +241.6% | 148,800 | +44.0% | 0.63% | +260.9% |
| ADRO | Sell | ADURO BIOTECH INC | $7,785,000 | -21.9% | 3,369,976 | -7.4% | 0.62% | -17.3% |
| CHMA | Sell | CHIASMA INC | $7,691,000 | +1.5% | 1,429,633 | -31.1% | 0.61% | +7.4% |
| ZYME | New | ZYMEWORKS INCput | $7,676,000 | – | 212,800 | +100.0% | 0.61% | – |
| KURA | Sell | KURA ONCOLOGY INC | $7,590,000 | +0.4% | 465,619 | -38.7% | 0.60% | +6.2% |
| ADVM | Buy | ADVERUM BIOTECHNOLOGIES INCcall | $7,490,000 | -26.6% | 358,700 | +59.8% | 0.60% | -22.4% |
| BDTX | New | BLACK DIAMOND THERAPEUTICS I | $7,485,000 | – | 177,544 | +100.0% | 0.60% | – |
| ICPT | Buy | INTERCEPT PHARMACEUTICALS INcall | $7,187,000 | +128.3% | 150,000 | +200.0% | 0.57% | +141.4% |
| IMVT | Sell | IMMUNOVANT INC | $6,871,000 | -47.6% | 282,163 | -66.5% | 0.55% | -44.5% |
| GBT | New | GLOBAL BLOOD THERAPEUTICS INput | $6,446,000 | – | 102,100 | +100.0% | 0.51% | – |
| BLUE | Buy | BLUEBIRD BIO INC | $6,402,000 | +2041.1% | 104,874 | +1513.9% | 0.51% | +2213.6% |
| DCPH | New | DECIPHERA PHARMACEUTICALS INput | $5,972,000 | – | 100,000 | +100.0% | 0.48% | – |
| RARE | Sell | ULTRAGENYX PHARMACEUTICAL INcall | $5,749,000 | +29.4% | 73,500 | -26.5% | 0.46% | +37.1% |
| CBAY | Sell | CYMABAY THERAPEUTICS INC | $5,339,000 | +52.4% | 1,529,830 | -35.4% | 0.42% | +61.6% |
| AUPH | Buy | AURINIA PHARMACEUTICALS INC | $5,326,000 | +67.8% | 327,771 | +49.8% | 0.42% | +77.4% |
| ARVN | New | ARVINAS INCput | $5,165,000 | – | 154,000 | +100.0% | 0.41% | – |
| KDMN | Sell | KADMON HLDGS INC | $5,023,000 | -9.0% | 981,070 | -25.5% | 0.40% | -3.6% |
| TCDA | Sell | TRICIDA INC | $4,864,000 | +23.0% | 177,002 | -1.6% | 0.39% | +29.9% |
| MDGL | Buy | MADRIGAL PHARMACEUTICALS INC | $4,819,000 | +78.9% | 42,554 | +5.5% | 0.38% | +89.2% |
| EIDX | New | EIDOS THERAPEUTICS INC | $4,767,000 | – | 100,000 | +100.0% | 0.38% | – |
| CARA | Sell | CARA THERAPEUTICS INC | $4,677,000 | -35.9% | 273,524 | -50.5% | 0.37% | -32.2% |
| BMRN | New | BIOMARIN PHARMACEUTICAL INCcall | $4,650,000 | – | 37,700 | +100.0% | 0.37% | – |
| PCVX | New | VAXCYTE INC | $4,419,000 | – | 139,813 | +100.0% | 0.35% | – |
| CHAQU | New | CHARDAN HEALTHCR ACQSTN 2 COunit 99/99/9999 | $4,200,000 | – | 400,000 | +100.0% | 0.33% | – |
| AVDL | Buy | AVADEL PHARMACEUTICALS PLCsponsored adr | $3,936,000 | +503.7% | 487,143 | +493.0% | 0.31% | +538.8% |
| BMYRT | Buy | BRISTOL-MYERS SQUIBB COright 99/99/9999 | $3,938,000 | +9.1% | 1,100,000 | +15.8% | 0.31% | +15.5% |
| OTIC | Sell | OTONOMY INC | $3,864,000 | +43.4% | 1,067,271 | -21.9% | 0.31% | +51.7% |
| XENE | Sell | XENON PHARMACEUTICALS INC | $3,739,000 | -25.7% | 298,173 | -32.8% | 0.30% | -21.2% |
| ASMB | ASSEMBLY BIOSCIENCES INC | $3,672,000 | +57.3% | 157,468 | 0.0% | 0.29% | +65.9% | |
| BHVN | Sell | BIOHAVEN PHARMACTL HLDG CO Lcall | $3,656,000 | -69.3% | 50,000 | -85.7% | 0.29% | -67.5% |
| CLDX | New | CELLDEX THERAPEUTICS INC NEWcall | $3,569,000 | – | 274,500 | +100.0% | 0.28% | – |
| ARVN | Buy | ARVINAS INCcall | $3,559,000 | +57.4% | 106,100 | +89.1% | 0.28% | +66.5% |
| NKTR | New | NEKTAR THERAPEUTICScall | $3,474,000 | – | 150,000 | +100.0% | 0.28% | – |
| ZGNX | Sell | ZOGENIX INCcall | $3,314,000 | -37.1% | 122,700 | -42.4% | 0.26% | -33.3% |
| VSTM | Sell | VERASTEM INC | $3,291,000 | -76.3% | 1,913,327 | -63.6% | 0.26% | -74.9% |
| XLRN | Sell | ACCELERON PHARMA INCput | $3,287,000 | -88.5% | 34,500 | -89.1% | 0.26% | -87.8% |
| FGEN | FIBROGEN INCput | $3,242,000 | +16.6% | 80,000 | 0.0% | 0.26% | +23.4% | |
| ZYNE | New | ZYNERBA PHARMACEUTICALS INCcall | $3,240,000 | – | 961,400 | +100.0% | 0.26% | – |
| CLVS | Sell | CLOVIS ONCOLOGY INCcall | $3,219,000 | -34.7% | 476,900 | -38.5% | 0.26% | -31.0% |
| TORC | New | RESTORBIO INC | $3,123,000 | – | 1,452,551 | +100.0% | 0.25% | – |
| ICAD | Buy | ICAD INC | $3,120,000 | +296.9% | 312,268 | +191.6% | 0.25% | +320.3% |
| RIGL | RIGEL PHARMACEUTICALS INC | $3,075,000 | +17.3% | 1,680,529 | 0.0% | 0.24% | +24.4% | |
| ALLK | New | ALLAKOS INC | $3,057,000 | – | 42,536 | +100.0% | 0.24% | – |
| AGTC | APPLIED GENETIC TECHNOLOGIES | $3,024,000 | +68.9% | 545,884 | 0.0% | 0.24% | +78.5% | |
| ALBO | ALBIREO PHARMA INCcall | $2,662,000 | +61.8% | 100,500 | 0.0% | 0.21% | +71.0% | |
| SLNO | New | SOLENO THERAPEUTICS INCput | $2,617,000 | – | 1,178,800 | +100.0% | 0.21% | – |
| CASI | CASI PHARMACEUTICALS INC | $2,600,000 | +22.6% | 1,039,910 | 0.0% | 0.21% | +29.4% | |
| APTX | APTINYX INC | $2,464,000 | +93.0% | 591,000 | 0.0% | 0.20% | +104.2% | |
| KURA | New | KURA ONCOLOGY INCcall | $2,445,000 | – | 150,000 | +100.0% | 0.20% | – |
| ZYNE | New | ZYNERBA PHARMACEUTICALS INCput | $2,334,000 | – | 692,500 | +100.0% | 0.19% | – |
| SLNO | New | SOLENO THERAPEUTICS INCcall | $2,331,000 | – | 1,050,000 | +100.0% | 0.19% | – |
| NERV | Buy | MINERVA NEUROSCIENCES INCcall | $2,316,000 | +12.6% | 641,600 | +87.8% | 0.18% | +18.7% |
| SLDB | Buy | SOLID BIOSCIENCES INC | $2,309,000 | +79.3% | 788,008 | +46.2% | 0.18% | +89.7% |
| ACAD | New | ACADIA PHARMACEUTICALS INC | $2,230,000 | – | 46,008 | +100.0% | 0.18% | – |
| ZYNE | New | ZYNERBA PHARMACEUTICALS INC | $2,182,000 | – | 647,400 | +100.0% | 0.17% | – |
| BLUE | Sell | BLUEBIRD BIO INCcall | $2,136,000 | -33.6% | 35,000 | -50.0% | 0.17% | -29.8% |
| New | HORIZON THERAPEUTICS PUB LTD | $2,092,000 | – | 37,641 | +100.0% | 0.17% | – | |
| ADVM | New | ADVERUM BIOTECHNOLOGIES INCput | $1,979,000 | – | 94,800 | +100.0% | 0.16% | – |
| MRNA | New | MODERNA INCcall | $1,926,000 | – | 30,000 | +100.0% | 0.15% | – |
| ALT | New | ALTIMMUNE INC | $1,767,000 | – | 165,000 | +100.0% | 0.14% | – |
| FATE | FATE THERAPEUTICS INCcall | $1,719,000 | +54.4% | 50,100 | 0.0% | 0.14% | +63.1% | |
| FATE | FATE THERAPEUTICS INCput | $1,719,000 | +54.4% | 50,100 | 0.0% | 0.14% | +63.1% | |
| ICPT | Sell | INTERCEPT PHARMACEUTICALS INput | $1,701,000 | -84.3% | 35,500 | -79.4% | 0.14% | -83.4% |
| MCRB | New | SERES THERAPEUTICS INCput | $1,677,000 | – | 352,300 | +100.0% | 0.13% | – |
| AXSM | Sell | AXSOME THERAPEUTICS INCcall | $1,506,000 | -93.2% | 18,300 | -95.1% | 0.12% | -92.8% |
| ACHV | New | ACHIEVE LIFE SCIENCE INC | $1,452,000 | – | 3,658,537 | +100.0% | 0.12% | – |
| CLLS | Buy | CELLECTIS S Aspon ads | $1,301,000 | +356.5% | 73,067 | +136.2% | 0.10% | +395.2% |
| NERV | Buy | MINERVA NEUROSCIENCES INCput | $1,250,000 | -25.5% | 346,300 | +24.3% | 0.10% | -21.4% |
| MCRB | New | SERES THERAPEUTICS INCcall | $1,190,000 | – | 250,000 | +100.0% | 0.10% | – |
| MBIO | MUSTANG BIO INC | $1,134,000 | +18.7% | 356,475 | 0.0% | 0.09% | +25.0% | |
| ADMA | Sell | ADMA BIOLOGICS INC | $1,109,000 | -38.9% | 378,574 | -39.9% | 0.09% | -35.3% |
| OTIC | OTONOMY INCcall | $1,086,000 | +83.8% | 300,000 | 0.0% | 0.09% | +95.5% | |
| CERC | Sell | CERECOR INC | $1,047,000 | -25.2% | 402,865 | -28.6% | 0.08% | -21.0% |
| BBIO | New | BRIDGEBIO PHARMA INCcall | $1,027,000 | – | 31,500 | +100.0% | 0.08% | – |
| DCTH | New | DELCATH SYS INC | $964,000 | – | 94,000 | +100.0% | 0.08% | – |
| SLNO | New | SOLENO THERAPEUTICS INC | $748,000 | – | 336,801 | +100.0% | 0.06% | – |
| DBVT | Sell | DBV TECHNOLOGIES S Asponsored adr | $723,000 | -19.1% | 164,730 | -27.8% | 0.06% | -13.4% |
| KNSA | Sell | KINIKSA PHARMACEUTICALS LTD | $720,000 | -87.0% | 28,274 | -92.1% | 0.06% | -86.4% |
| IFRX | Sell | INFLARX NV | $700,000 | -30.2% | 152,600 | -41.9% | 0.06% | -25.3% |
| DRNA | Buy | DICERNA PHARMACEUTICALS INCcall | $648,000 | +127.4% | 25,500 | +64.5% | 0.05% | +147.6% |
| PBYI | PUMA BIOTECHNOLOGY INC | $573,000 | +23.8% | 54,901 | 0.0% | 0.05% | +31.4% | |
| IMMU | Sell | IMMUNOMEDICS INCcall | $571,000 | -63.5% | 16,100 | -86.1% | 0.04% | -61.9% |
| MYOV | Sell | MYOVANT SCIENCES LTD | $536,000 | -84.2% | 25,999 | -94.2% | 0.04% | -83.2% |
| AXGT | AXOVANT GENE THERAPIES | $533,000 | +15.6% | 188,884 | 0.0% | 0.04% | +20.0% | |
| OBSV | OBSEVA SA | $486,000 | +144.2% | 82,573 | 0.0% | 0.04% | +160.0% | |
| ADVM | New | ADVERUM BIOTECHNOLOGIES INC | $477,000 | – | 22,840 | +100.0% | 0.04% | – |
| GILD | New | GILEAD SCIENCES INC | $478,000 | – | 6,218 | +100.0% | 0.04% | – |
| SRPT | Sell | SAREPTA THERAPEUTICS INCcall | $417,000 | -95.8% | 2,600 | -97.5% | 0.03% | -95.6% |
| BXRX | Sell | BAUDAX BIO INC | $415,000 | -4.4% | 100,000 | -42.9% | 0.03% | 0.0% |
| INCY | New | INCYTE CORP | $385,000 | – | 3,700 | +100.0% | 0.03% | – |
| ARGX | Sell | ARGENX SEsponsored adr | $394,000 | -95.5% | 1,750 | -97.3% | 0.03% | -95.2% |
| GNFT | New | GENFIT S Aads | $353,000 | – | 64,027 | +100.0% | 0.03% | – |
| CARA | CARA THERAPEUTICS INCcall | $335,000 | +29.3% | 19,600 | 0.0% | 0.03% | +42.1% | |
| ARNA | New | ARENA PHARMACEUTICALS INC | $315,000 | – | 5,000 | +100.0% | 0.02% | – |
| DRNA | New | DICERNA PHARMACEUTICALS INCput | $254,000 | – | 10,000 | +100.0% | 0.02% | – |
| SNDX | New | SYNDAX PHARMACEUTICALS INC | $237,000 | – | 16,000 | +100.0% | 0.02% | – |
| MLND | New | MILLENDO THERAPEUTICS INC | $238,000 | – | 135,193 | +100.0% | 0.02% | – |
| BIIB | BIOGEN INC | $213,000 | -15.5% | 795 | 0.0% | 0.02% | -10.5% | |
| LEGN | New | LEGEND BIOTECH CORPsponsored ads | $213,000 | – | 5,000 | +100.0% | 0.02% | – |
| ITCI | Sell | INTRA CELLULAR THERAPIES INC | $185,000 | -95.2% | 7,202 | -97.1% | 0.02% | -94.8% |
| RARE | Sell | ULTRAGENYX PHARMACEUTICAL IN | $181,000 | -71.4% | 2,313 | -83.8% | 0.01% | -70.8% |
| IWM | Sell | ISHARES TRrussell 2000 etf | $165,000 | -90.5% | 1,154 | -92.4% | 0.01% | -90.0% |
| SRRA | New | SIERRA ONCOLOGY INC | $118,000 | – | 9,658 | +100.0% | 0.01% | – |
| ANAB | New | ANAPTYSBIO INC | $102,000 | – | 4,581 | +100.0% | 0.01% | – |
| CLVS | Sell | CLOVIS ONCOLOGY INC | $101,000 | -96.1% | 14,918 | -96.4% | 0.01% | -95.9% |
| AEZS | AETERNA ZENTARIS INC | $94,000 | +56.7% | 117,443 | 0.0% | 0.01% | +40.0% | |
| DTIL | New | PRECISION BIOSCIENCES INC | $73,000 | – | 8,812 | +100.0% | 0.01% | – |
| INSM | Sell | INSMED INC | $80,000 | -97.1% | 2,919 | -98.3% | 0.01% | -97.1% |
| MITO | STEALTH BIOTHERAPEUTICS CORPsponsored ads | $69,000 | +46.8% | 37,597 | 0.0% | 0.01% | +25.0% | |
| MGTA | New | MAGENTA THERAPEUTICS INC | $65,000 | – | 8,674 | +100.0% | 0.01% | – |
| APLS | Sell | APELLIS PHARMACEUTICALS INC | $69,000 | -95.1% | 2,126 | -95.9% | 0.01% | -95.2% |
| ALPN | New | ALPINE IMMUNE SCIENCES INC | $46,000 | – | 4,739 | +100.0% | 0.00% | – |
| XFOR | New | X4 PHARMACEUTICALS INC | $47,000 | – | 5,000 | +100.0% | 0.00% | – |
| SNSS | SUNESIS PHARMACEUTICALS INC | $29,000 | -37.0% | 111,445 | 0.0% | 0.00% | -33.3% | |
| VKTX | Sell | VIKING THERAPEUTICS INC | $8,000 | -98.6% | 1,159 | -99.1% | 0.00% | -97.7% |
| AMRN | Exit | AMARIN CORP PLCcall | $0 | – | -39,700 | -100.0% | -0.01% | – |
| ARWR | Exit | ARROWHEAD PHARMACEUTICALS INput | $0 | – | -7,200 | -100.0% | -0.02% | – |
| DBVT | Exit | DBV TECHNOLOGIES S Aput | $0 | – | -52,800 | -100.0% | -0.02% | – |
| CMRX | Exit | CHIMERIX INC | $0 | – | -208,258 | -100.0% | -0.02% | – |
| MNKKQ | Exit | MALLINCKRODT PUB LTD CO | $0 | – | -194,322 | -100.0% | -0.03% | – |
| PGNX | Exit | PROGENICS PHARMACEUTICALS IN | $0 | – | -130,845 | -100.0% | -0.04% | – |
| KOD | Exit | KODIAK SCIENCES INCput | $0 | – | -11,800 | -100.0% | -0.04% | – |
| PFNX | Exit | PFENEX INC | $0 | – | -64,211 | -100.0% | -0.04% | – |
| NERV | Exit | MINERVA NEUROSCIENCES INC | $0 | – | -103,504 | -100.0% | -0.05% | – |
| KPTI | Exit | KARYOPHARM THERAPEUTICS INC | $0 | – | -36,422 | -100.0% | -0.05% | – |
| BLU | Exit | BELLUS HEALTH INC NEW | $0 | – | -63,721 | -100.0% | -0.07% | – |
| SLDB | Exit | SOLID BIOSCIENCES INCcall | $0 | – | -449,800 | -100.0% | -0.08% | – |
| PTGX | Exit | PROTAGONIST THERAPEUTICS INC | $0 | – | -158,222 | -100.0% | -0.08% | – |
| OVID | Exit | OVID THERAPEUTICS INC | $0 | – | -377,737 | -100.0% | -0.08% | – |
| CRTX | Exit | CORTEXYME INC | $0 | – | -25,000 | -100.0% | -0.09% | – |
| SAVA | Exit | CASSAVA SCIENCES INC | $0 | – | -300,000 | -100.0% | -0.09% | – |
| ALLK | Exit | ALLAKOS INCput | $0 | – | -30,000 | -100.0% | -0.10% | – |
| ALLK | Exit | ALLAKOS INCcall | $0 | – | -30,000 | -100.0% | -0.10% | – |
| CHRS | Exit | COHERUS BIOSCIENCES INCcall | $0 | – | -84,100 | -100.0% | -0.10% | – |
| AUPH | Exit | AURINIA PHARMACEUTICALS INCput | $0 | – | -100,000 | -100.0% | -0.11% | – |
| NXTC | Exit | NEXTCURE INCput | $0 | – | -40,700 | -100.0% | -0.11% | – |
| INO | Exit | INOVIO PHARMACEUTICALS INCput | $0 | – | -250,000 | -100.0% | -0.14% | – |
| RLMD | Exit | RELMADA THERAPEUTICS INC | $0 | – | -55,172 | -100.0% | -0.14% | – |
| MGNX | Exit | MACROGENICS INC | $0 | – | -360,030 | -100.0% | -0.16% | – |
| ASMB | Exit | ASSEMBLY BIOSCIENCES INCput | $0 | – | -150,000 | -100.0% | -0.17% | – |
| NTLA | Exit | INTELLIA THERAPEUTICS INC | $0 | – | -184,989 | -100.0% | -0.17% | – |
| BBIO | Exit | BRIDGEBIO PHARMA INC | $0 | – | -87,900 | -100.0% | -0.19% | – |
| ASND | Exit | ASCENDIS PHARMA A Sput | $0 | – | -70,000 | -100.0% | -0.28% | – |
| KALA | Exit | KALA PHARMACEUTICALS INC | $0 | – | -493,952 | -100.0% | -0.33% | – |
| CYTK | Exit | CYTOKINETICS INCput | $0 | – | -384,400 | -100.0% | -0.34% | – |
| INSM | Exit | INSMED INCcall | $0 | – | -300,000 | -100.0% | -0.36% | – |
| MYOK | Exit | MYOKARDIA INCcall | $0 | – | -113,400 | -100.0% | -0.40% | – |
| CYTK | Exit | CYTOKINETICS INCcall | $0 | – | -500,000 | -100.0% | -0.44% | – |
| AVDL | Exit | AVADEL PHARMACEUTICALS PLCcall | $0 | – | -750,000 | -100.0% | -0.45% | – |
| CCXI | Exit | CHEMOCENTRYX INCcall | $0 | – | -150,000 | -100.0% | -0.45% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INCcall | $0 | – | -150,000 | -100.0% | -0.48% | – |
| GLPG | Exit | GALAPAGOS NVcall | $0 | – | -35,000 | -100.0% | -0.52% | – |
| MLND | Exit | MILLENDO THERAPEUTICS INCput | $0 | – | -1,403,900 | -100.0% | -0.56% | – |
| NBIX | Exit | NEUROCRINE BIOSCIENCES INCcall | $0 | – | -100,000 | -100.0% | -0.65% | – |
| AXSM | Exit | AXSOME THERAPEUTICS INCput | $0 | – | -150,000 | -100.0% | -0.66% | – |
| ARGX | Exit | ARGENX SEcall | $0 | – | -75,000 | -100.0% | -0.74% | – |
| TARA | Exit | ARTARA THERAPEUTICS INC | $0 | – | -450,772 | -100.0% | -0.78% | – |
| KPTI | Exit | KARYOPHARM THERAPEUTICS INCput | $0 | – | -551,800 | -100.0% | -0.80% | – |
| ABBV | Exit | ABBVIE INCcall | $0 | – | -150,000 | -100.0% | -0.86% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INCput | $0 | – | -120,300 | -100.0% | -0.98% | – |
| LGND | Exit | LIGAND PHARMACEUTICALS INCcall | $0 | – | -200,000 | -100.0% | -1.09% | – |
| IWM | Exit | ISHARES TRput | $0 | – | -150,000 | -100.0% | -1.29% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INCcall | $0 | – | -200,000 | -100.0% | -1.35% | – |
| GILD | Exit | GILEAD SCIENCES INCcall | $0 | – | -250,000 | -100.0% | -1.41% | – |
| XBI | Exit | SPDR SER TRcall | $0 | – | -250,000 | -100.0% | -1.46% | – |
| XLRN | Exit | ACCELERON PHARMA INC | $0 | – | -239,249 | -100.0% | -1.62% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INCcall | $0 | – | -246,900 | -100.0% | -2.02% | – |
| QQQ | Exit | INVESCO QQQ TRput | $0 | – | -550,000 | -100.0% | -2.22% | – |
| BIIB | Exit | BIOGEN INCcall | $0 | – | -143,400 | -100.0% | -3.41% | – |
| REGN | Exit | REGENERON PHARMACEUTICALSput | $0 | – | -130,000 | -100.0% | -4.77% | – |
| SPY | Exit | SPDR S&P 500 ETF TRcall | $0 | – | -250,000 | -100.0% | -4.85% | – |
| TLT | Exit | ISHARES TRput | $0 | – | -400,000 | -100.0% | -4.96% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| XENON PHARMACEUTICALS INC | 15 | Q2 2023 | 1.5% |
| OCULAR THERAPEUTIX INC | 15 | Q3 2023 | 1.4% |
| SAREPTA THERAPEUTICS INC | 14 | Q3 2023 | 6.4% |
| X4 PHARMACEUTICALS INC - PIPE | 14 | Q2 2023 | 1.4% |
| PROTARA THERAPEUTICS INC | 14 | Q3 2023 | 1.2% |
| SPDR SER TR | 13 | Q3 2023 | 9.0% |
| VAXCYTE INC | 13 | Q3 2023 | 2.9% |
| TRACON PHARMACEUTICALS INC | 13 | Q3 2023 | 1.4% |
| MILESTONE PHARMACEUTICALS IN | 13 | Q3 2023 | 1.7% |
| BELLUS HEALTH INC NEW | 13 | Q1 2023 | 1.8% |
View Ikarian Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Milestone Pharmaceuticals Inc. | February 14, 2023 | 460,416 | 1.3% |
| X4 Pharmaceuticals, Inc | February 14, 2023 | 349,133 | 0.3% |
| aTYR PHARMA INC | February 14, 2022 | 35,048 | 0.1% |
| Cyclacel Pharmaceuticals, Inc. | February 14, 2022 | 99,422 | 1.0% |
| KalVista Pharmaceuticals, Inc. | February 14, 2022 | 36,576 | 0.2% |
| Lyra Therapeutics, Inc. | February 14, 2022 | 394,536 | 3.0% |
| Odonate Therapeutics, Inc. | February 14, 2022 | 1,340,631 | 3.5% |
| Protara Therapeutics, Inc. | February 14, 2022 | 279,256 | 2.5% |
| Science 37 Holdings, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| scPharmaceuticals Inc. | February 14, 2022 | 901,362 | 3.3% |
View Ikarian Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-04-05 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
View Ikarian Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.